Abstract
The best endoscopic diagnostic strategy for gastrointestinal (GI) graft-versus-host disease (GVHD) is unknown. Over a 48-month period, all patients with unexplained diarrhea at risk for acute gastrointestinal GVHD were prospectively identified. Acute GVHD was defined as symptoms and histologic evidence of GVHD occurring within 100 days of transplant or donor lymphocyte infusion (DLI). Colonoscopy was performed with multiple biopsies of the ileum, right colon and rectosigmoid colon. Next, upper endoscopy with duodenal and random gastric biopsies of both antrum and body were performed. All biopsies were evaluated for GVHD by an experienced GI pathologist. Over the study period, 24 patients (mean age 37 years; 62.5% male) were evaluated. The median time from transplantation or DLI was 30.5 days. The biopsy site with the highest yield was the distal colon (82%). A combination of upper endoscopy with sigmoidoscopy and colonoscopy with ileal biopsies were equivalent (∼94%). In patients with diarrhea at risk for GVHD, biopsies of the distal colon had the highest diagnostic yield suggesting the importance of sigmoidoscopy and biopsy. Colonoscopy and ileoscopy or flexible sigmoidoscopy plus upper endoscopy had the highest diagnostic yields.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kreisel W, Herbst EW, Schwind B, Ochs A, Olschewski M, Kochling G et al. Diagnosis and grading of acute graft-versus-host disease following allogeneic bone marrow transplantation by sigmoidoscopy. Eur J Gastroenterol Hepatol 1994; 6: 723–729.
Bombi JA, Nadal A, Carreras E, Ramirez J, Munoz J, Rozman C et al. Assessment of histopathologic changes in the colonic biopsy in acute graft-versus-host disease. Am J Clin Pathol 1995; 103: 690–695.
Ferrara JL, Deeg HJ . Graft-versus-host disease. N Engl J Med 1991; 324: 667–674.
Fallows G, Rubinger M, Bernstein CN . Does gastroenterology consultation change management of patients receiving hematopoietic stem cell transplantation? Bone Marrow Transplant 2001; 28: 289–294.
Cox GJ, Matsui SM, Lo RS, Hinds M, Bowden RA, Hackman RC et al. Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology 1994; 107: 1398–1407.
Goker J, Haznedaroglu IC, Chao NJ . Acute graft-versus-host disease: pathobiology and management. Exp Hematol 2001; 29: 259–277.
Ponec RJ, Hackman RC, McDonald GB . Endoscopic and histologic diagnosis of intestinal graft-versus-host disease after marrow transplantation. Gastrointest Endosc 1999; 49: 612–621.
Roy J, Snover D, Weisdorf S, Mulvahill A, Filipovich A, Weisdorf D . Simultaneous upper and lower endoscopic biopsy in the diagnosis of intestinal graft-versus-host disease. Transplantation 1991; 51: 642–646.
Epstein RJ, McDonald GB, Sale GE, Shulman HM, Thomas ED . The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients. Gastroenterology 1980; 78: 764–771.
Santos GW, Owens AH . Production of graft-versus-host disease in the rat and its treatment with cytotoxic agents. Nature 1966; 210: 139–140.
Storb R, Epstein RB, Graham TC, Thomas ED . Methotrexate regimens for control of graft-versus host disease in dogs with allogeneic marrow grafts. Transplantation 1970; 9: 204–246.
Storb R, Deeg HJ, Pepe M, Doney K, Appelbaum F, Beatty P et al. Graft-versus-host disease prevention by methotrexate combined with cyclosporine compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long term follow-up of a controlled trial. Br J Haematol 1989; 72: 567–572.
Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia. N Eng J Med 1986; 314: 729–735.
Storb R, Deeg HJ, Pepe M, Appelbaum F, Anasetti C, Beatty P et al. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial. Blood 1989; 73: 1729–1734.
McDonald GB, Sale GE . The human gastrointestinal tract after allogeneic marrow transplantation. In: Sale GI, Shulman HM (eds). The Pathology of Bone Marrow Transplantation. Masson: New York, 1984, p. 83.
Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A matched sibling donors. Transplantation 1974; 18: 295–304.
Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825–828.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thompson, B., Salzman, D., Steinhauer, J. et al. Prospective endoscopic evaluation for gastrointestinal graft-versus-host disease: determination of the best diagnostic approach. Bone Marrow Transplant 38, 371–376 (2006). https://doi.org/10.1038/sj.bmt.1705453
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705453
Keywords
This article is cited by
-
Acute graft-versus-host disease
Nature Reviews Disease Primers (2023)
-
PET assessment of acute gastrointestinal graft versus host disease
Bone Marrow Transplantation (2023)
-
Round-Robin test for the histological diagnosis of acute colonic Graft-versus-Host disease validating established histological criteria and grading systems
Virchows Archiv (2023)
-
Histological and magnified endoscopic evaluation of villous atrophy in gastrointestinal graft-versus-host disease
Annals of Hematology (2020)
-
Non-invasive diagnosis of acute intestinal graft-versus-host disease by a new scoring system using ultrasound morphology, compound elastography, and contrast-enhanced ultrasound
Bone Marrow Transplantation (2019)